Melanom kliniske forsøg i Arizona
26 studier for Melanom søger deltagere på steder i Arizona.
Byer i Arizona
Officiel studietekst (engelsk)
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- HonorHealth Research Institute, Scottsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07751042Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Mayo Clinic Hospital in Arizona, Phoenix
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Ironwood Cancer & Research Centers, Chandler
- Banner MD Anderson Cancer Center, Gilbert
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06246916Pan-tumor MRD Study
- Mohtaseb Cancer Center and Blood Disorders, Bullhead City
- Cancer & Blood Specialists of Arizona, Casa Grande
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Cancer Center at Saint Joseph's, Phoenix
RekruttererFase 3
Alder 75 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07068074Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT06814496ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05059444DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
- Banner MD Anderson Cancer Center, Gilbert
- Arizona State University-Honor Health Research Institute, Scottsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07288112Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Arizona, Tucson
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07287917A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Mayo Clinic Arizona, Phoenix
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Kingman Regional Medical Center, Kingman
- Banner Children's at Desert, Mesa
- Phoenix Childrens Hospital, Phoenix
- og 1 flere
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
- HonorHealth Research Institute, Scottsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT06425926Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Mayo Clinic Scottsdale - PPDS, Scottsdale
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- HonorHealth Research Insisute, Scottsdale
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 2. apr. 2026 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. mar. 2026 · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Mayo Clinic Arizona, Phoenix
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT05549297Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Mayo Clinic Hospital, Phoenix
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT03567889A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. nov. 2025 · NCT05914116Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- HonorHealth Research and Innovation Institute, Scottsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. okt. 2025 · NCT06249048SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Phoenix, Phoenix
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 27. nov. 2024 · NCT03860883A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Arizona, Scottsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. nov. 2024 · NCT05824975Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- HonorHealth Research Institute, Scottsdale
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. nov. 2024 · NCT04787042Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- HonorHealth Research Institute, Scottsdale
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 8. feb. 2024 · NCT04282044Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.